Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis

被引:89
作者
Alsenz, J [1 ]
Haenel, E [1 ]
机构
[1] F Hoffmann La Roche & Co Ltd, Preclin Res Dept, Div Pharma, CH-4002 Basel, Switzerland
关键词
Caco-2; cells; permeability; biopharmaceutics classification system; high-throughput; oral absorption;
D O I
10.1023/B:PHAM.0000008043.71001.43
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The aim was to replace the traditional 21-day Caco-2 permeability protocol by a more high-throughput assay. Methods. Caco-2 cells were seeded at high density in 96-well plates in novel cell culture boxes. After 7 days, drug permeability studies were performed. Samples were analyzed by a new UV detection method. Results. With increased cell seeding density, functional Caco-2 monolayers with polarized efflux transporters were established after 7 days in 96-well polycarbonate filter plates in standard medium. For faster feeding and to eliminate medium replacement in each individual well, plates were completely submerged in medium in novel cell culture boxes, and only medium outside the plate was exchanged. For high-throughput sample analysis, a novel UV-transparent transport buffer was established that allowed direct quantification of permeated drug from its UV absorption. In vitro permeability studies analyzing 22 passively absorbed drugs in the new model correlated well with reported human permeability values (r(2) = 0.8725). Conclusions. The new 7-day, 96-well Caco-2 permeability model tight to UV analysis offers considerable time, cost, and resource savings compared to the traditional model. It has a potential for automation and makes it possible to determine the permeability of passively diffusing compounds and to classify them according to the BCS in a truly medium-to high-throughput mode.
引用
收藏
页码:1961 / 1969
页数:9
相关论文
共 31 条
[1]   Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers [J].
Alsenz, J ;
Steffen, H ;
Alex, R .
PHARMACEUTICAL RESEARCH, 1998, 15 (03) :423-428
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]  
AMIDON GL, 1996, 2 INT WORKSH STRAT O
[4]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[5]   Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[6]   Absorption classification of oral drugs based on molecular surface properties [J].
Bergström, CAS ;
Strafford, M ;
Lazorova, L ;
Avdeef, A ;
Luthman, K ;
Artursson, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (04) :558-570
[7]   The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins [J].
Bogman, K ;
Erne-Brand, F ;
Alsenz, J ;
Drewe, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (06) :1250-1261
[8]  
Bu HZ, 2000, RAPID COMMUN MASS SP, V14, P523, DOI 10.1002/(SICI)1097-0231(20000331)14:6<523::AID-RCM906>3.3.CO
[9]  
2-K
[10]   Evaluation of Biocoat® intestinal epithelium differentiation environment (3-day cultured Caco-2 cells) as an absorption screening model with improved productivity [J].
Chong, SH ;
Dando, SA ;
Morrison, RA .
PHARMACEUTICAL RESEARCH, 1997, 14 (12) :1835-1837